المؤلفون: Child F; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, U.K., Ortiz-Romero PL; Department of Dermatology, 12 de Octubre Hospital, Institute i+12, Medical School, Complutense University, Madrid, Spain., Alvarez R; Portuguese Institute of Oncology, Lisbon, Portugal., Bagot M; Department of Dermatology, Saint-Louis Hospital, Paris 7 University, Paris, France., Stadler R; Department of Dermatology, Johannes Wesling Medical Center, Minden, Germany., Weichenthal M; Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany., Alves R; Department of Dermatology, Hospital de Santo António - Centro Hospitalar do Porto, Porto, Portugal., Quaglino P; Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy., Beylot-Barry M; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Cowan R; Manchester Academic Health Science Centre, Christie Hospital, Manchester, U.K., Geskin LJ; School of Medicine, Department of Dermatology, University of Pittsburgh, Pittsburgh, PA, U.S.A., Pérez-Ferriols A; Department of Dermatology, University General Hospital, Valencia, Spain., Hellemans P; Janssen Research & Development, Beerse, Belgium., Elsayed Y; Janssen Research & Development, Titusville, NJ, U.S.A., Phelps C; Janssen Research & Development, Titusville, NJ, U.S.A., Forslund A; Janssen Research & Development, Spring House, PA, U.S.A., Kamida M; Janssen Pharmaceutical K.K., Tokyo, Japan., Zinzani PL; Institute of Hematology 'Seràgnoli', University of Bologna, Bologna, Italy.

المصدر: The British journal of dermatology [Br J Dermatol] 2016 Jul; Vol. 175 (1), pp. 80-8. Date of Electronic Publication: 2016 Jun 02.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Histone Deacetylase Inhibitors/*administration & dosage , Hydroxamic Acids/*administration & dosage , Mycosis Fungoides/*drug therapy , Sezary Syndrome/*drug therapy , Skin Neoplasms/*drug therapy, Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Biomarkers, Tumor/metabolism ; Disease-Free Survival ; Drug Administration Schedule ; Female ; Histone Deacetylase Inhibitors/adverse effects ; Humans ; Hydroxamic Acids/adverse effects ; Male ; Middle Aged ; Pruritus/prevention & control ; Retreatment ; Treatment Outcome

المؤلفون: Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. Electronic address: reinhard.dummer@usz.ch., Duvic M; Department of Dermatology, MD Anderson Cancer Center, Houston, USA., Scarisbrick J; Department Dermatology, Hospital Birmingham, Birmingham, UK., Olsen EA; Department of Dermatology, Duke University Medical Center, Durham, USA., Rozati S; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Eggmann N; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Goldinger SM; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Hutchinson K; Clinical Research, AMS Ltd, London, UK., Geskin L; Department of Dermatology, University of Pittsburgh, Pittsburgh, USA., Illidge TM; School of Cancer and Imaging Sciences, University of Manchester, Manchester, UK., Giuliano E; Clinical Development, BioCryst Pharmaceuticals, Inc., Durham., Elder J; Statistics, PharPoint Research, Inc., Chapel Hill., Kim YH; Clinical Research, Stanford Cancer Center, Stanford, USA.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Sep; Vol. 25 (9), pp. 1807-1812. Date of Electronic Publication: 2014 Jun 19.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Mycosis Fungoides/*drug therapy , Purine Nucleosides/*therapeutic use , Pyrimidinones/*therapeutic use , Sezary Syndrome/*drug therapy , Skin Neoplasms/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Apoptosis/drug effects ; Female ; Humans ; Male ; Middle Aged ; Purine Nucleosides/adverse effects ; Purine-Nucleoside Phosphorylase/antagonists & inhibitors ; Pyrimidinones/adverse effects ; Treatment Failure

المؤلفون: Duvic M; Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. mduvic@mdanderson.org, Geskin L, Prince HM

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2013 Aug; Vol. 13 (4), pp. 377-84. Date of Electronic Publication: 2013 Jun 14.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Diphtheria Toxin/*therapeutic use , Interleukin-2/*therapeutic use , Lymphoma, T-Cell, Cutaneous/*drug therapy , Skin Neoplasms/*drug therapy, Antineoplastic Agents/adverse effects ; Diphtheria Toxin/adverse effects ; Female ; Humans ; Interleukin-2/adverse effects ; Lymphoma, T-Cell, Cutaneous/pathology ; Male ; Middle Aged ; Recombinant Fusion Proteins/adverse effects ; Recombinant Fusion Proteins/therapeutic use ; Skin Neoplasms/pathology ; Treatment Outcome

المؤلفون: McCann S; Department of Dermatology, University of Pittsburgh, Pennsylvania, USA. mccannsa@upmc.edu, Akilov OE, Geskin L

المصدر: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2012 Oct; Vol. 16 (5), pp. E164-72.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Oncology Nursing Press Country of Publication: United States NLM ID: 9705336 Publication Model: Print Cited Medium: Internet ISSN: 1538-067X (Electronic) Linking ISSN: 10921095 NLM ISO Abbreviation: Clin J Oncol Nurs

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Diphtheria Toxin/*adverse effects , Interleukin-2/*adverse effects , Lymphoma, T-Cell/*drug therapy , Skin Neoplasms/*drug therapy, Antineoplastic Agents/therapeutic use ; Clinical Trials, Phase III as Topic ; Diphtheria Toxin/therapeutic use ; Humans ; Interleukin-2/therapeutic use ; Recombinant Fusion Proteins/adverse effects ; Recombinant Fusion Proteins/therapeutic use

المؤلفون: Alinari L; Division of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH 43210, USA., Geskin L, Grady T, Baiocchi RA, Bechtel MA, Porcu P

المصدر: Leukemia research [Leuk Res] 2008 Aug; Vol. 32 (8), pp. 1299-303. Date of Electronic Publication: 2007 Dec 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0145-2126 (Print) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Antibodies, Neoplasm/*administration & dosage , Antineoplastic Agents/*administration & dosage , Sezary Syndrome/*drug therapy, Aged, 80 and over ; Alemtuzumab ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Antibodies, Neoplasm/adverse effects ; Antineoplastic Agents/adverse effects ; Female ; Humans ; Injections, Subcutaneous ; Male

المؤلفون: Geskin L; Department of Dermatology, University of Pittsburgh, Melanoma Center UPCI, Pittsburgh, PA 15213, USA., Brown CR, Kirkwood JM

المصدر: Seminars in cutaneous medicine and surgery [Semin Cutan Med Surg] 2003 Mar; Vol. 22 (1), pp. 55-67.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 9617260 Publication Model: Print Cited Medium: Print ISSN: 1085-5629 (Print) Linking ISSN: 10855629 NLM ISO Abbreviation: Semin Cutan Med Surg Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Melanoma/*drug therapy , Skin Neoplasms/*drug therapy, Cancer Vaccines/therapeutic use ; Chemotherapy, Adjuvant ; Humans ; Immunotherapy ; Interferons/therapeutic use ; Interleukins/therapeutic use ; Randomized Controlled Trials as Topic